Orthopaedic Device Manufacturer Taps Seven-time PGA TOUR Winner to Lead Patient Education Campaign

GAINESVILLE, Fla. -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has partnered with professional golfer Peter Jacobsen to tell the story of his successful knee replacement with Exactech’s Optetrak® total knee system in 2008.

“When considering something as serious as knee replacement surgery, I knew it was important to do my homework,” said Jacobsen. “I wanted proven technology so I could resume my playing career and Exactech’s Optetrak knee system has me feeling better than ever.”

Jacobsen’s success story resulted in an impromptu meeting with Exactech last fall where he personally thanked the Gainesville-based employees for getting him back on the course. The relationship has evolved into an endorsement agreement, through which Jacobsen and Exactech are developing a patient education campaign to help other arthritis sufferers learn about today’s treatments for knee pain.

“Peter’s personality is the perfect voice for our company,” said Exactech spokesperson Priscilla Bennett. “His experience with knee pain resonates with other arthritis sufferers who want to return to the activities they enjoy, and for many, that means golf.”

Additional details of the patient education campaign involving Jacobsen are forthcoming. Information on knee replacement, including a database of surgeons who use the Optetrak knee system, is available through the website www.exac.com/peterjacobsen.

About Exactech
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States and Australia, in addition to more than 30 markets in Europe, Asia and Latin America. Additional information about Exactech, Inc. can be found at www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at www.exac.com and www.hawkassociates.com.

An investment profile on Exactech may be found at www.hawkassociates.com/profile/exac.cfm.

Investors may contact Chief Financial Officer Jody Phillips at 352-377-1140 or Julie Marshall or Frank Hawkins, Hawk Associates Inc., at 305-451-1888, e-mail: exactech@hawkassociates.com. To receive future releases in e-mail alerts, sign up at www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

PDF